Patients with advanced and metastatic renal cell carcinoma treated with targeted tgerapy in the Czech Republic: twenty cancer centres, six agnets, one database

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00209805%3A_____%2F12%3A%230000368" target="_blank" >RIV/00209805:_____/12:#0000368 - isvavai.cz</a>
Result on the web
<a href="http://link.springer.com.proxy.mzk.cz/article/10.1007%2Fs12032-012-0286-9" target="_blank" >http://link.springer.com.proxy.mzk.cz/article/10.1007%2Fs12032-012-0286-9</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s12032-012-0286-9" target="_blank" >10.1007/s12032-012-0286-9</a>

Result language
angličtina
Original language name
Patients with advanced and metastatic renal cell carcinoma treated with targeted tgerapy in the Czech Republic: twenty cancer centres, six agnets, one database
Original language description
The incidence and mortality of renal cell carcinoma (RCC) in the Czech Republic are among the highest in the world. Several targeted agents have been recently approved for the treatment of advanced/metastatic RCC. Objective: Presentation of a national clinical database for monitoring and assessment of patients with advanced/metastatic RCC treated with targeted therapy. The RenIS (RENal Information System, http://renis.registry.cz) registry is a non-interventional post-registration database of epidemiological and clinical data of patients with RCC treated with targeted therapies in the Czech Republic. Twenty cancer centres eligible for targeted therapy administration participate in the project. As of November 2011, six agents were approved and reimbursed from public health insurance, including bevacizumab, everolimus, pazopanib, sorafenib, sunitinib, and temsirolimus. As of 10 October 2011, 1,541 patients with valid records were entered into the database. Comparison with population-base
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—

Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)